Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: the Cornell voltage
- PMID: 10803469
- DOI: 10.1007/BF03343696
Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: the Cornell voltage
Abstract
Both type 2 diabetes mellitus (DM2) and left ventricular hypertrophy are associated with an increased risk of cardiovascular diseases (CVD). A strong association between hyperinsulinemia, which is the hallmark of DM2 and of insulin resistance syndrome (a cohort of metabolic abnormalities such as DM2, dyslipidemia, hyperuricemia, obesity, hypertension, hyperfibrinogenemia), and left ventricular (LV) hypertrophy was found in several studies. We studied 140 consecutive (both normo- and hypertensive) DM2 patients to determine a possible link between metabolic features and the degree of LV mass, calculated by the ECG method of Cornell voltage. The Cornell voltage value was 12.9+/-0.5 mm in the DM2 population as a whole, and 13.6+/-0.7 vs 11.7+/-0.9 mm (p=NS) in hypertensive and normotensive DM2 subgroups, respectively. Among all the metabolic parameters taken into account, the multivariate analysis shows that the fasting plasma insulin level is the strongest independent predictor of LV mass, both in the whole population (p=0.0005) and in the normo (p=0.0460) and hypertensive DM2 (p=0.0184) subgroups.
Similar articles
-
Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.J Hypertens. 2007 May;25(5):1079-85. doi: 10.1097/HJH.0b013e3280825638. J Hypertens. 2007. PMID: 17414673
-
Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.J Hum Hypertens. 1991 Apr;5(2):101-6. J Hum Hypertens. 1991. PMID: 1830106
-
Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity.J Am Coll Cardiol. 1996 Jan;27(1):124-31. doi: 10.1016/0735-1097(95)00421-1. J Am Coll Cardiol. 1996. PMID: 8522685 Clinical Trial.
-
Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.J Hypertens. 2013 Oct;31(10):2060-8. doi: 10.1097/HJH.0b013e328362bbd6. J Hypertens. 2013. PMID: 23838656 Clinical Trial.
-
Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.J Electrocardiol. 2014 Sep-Oct;47(5):630-5. doi: 10.1016/j.jelectrocard.2014.07.003. Epub 2014 Jul 3. J Electrocardiol. 2014. PMID: 25052475 Review.
Cited by
-
Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.Int J Mol Sci. 2021 Mar 24;22(7):3321. doi: 10.3390/ijms22073321. Int J Mol Sci. 2021. PMID: 33805039 Free PMC article. Review.
-
Development of metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects.J Endocrinol Invest. 2013 Dec;36(11):1027-31. doi: 10.3275/9035. Epub 2013 Jul 15. J Endocrinol Invest. 2013. PMID: 23873328
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous